Get started
Author

S. Londono

Observed names: S Londono, Santiago Sánchez, Santiago Sánchez Londoño
ORCID: 0000-0002-5554-8132
Observed ORCID: 0000-0002-5554-8132
OpenAlex ID: A5053201600
Descripción clínico-epidemiológica de pacientes con enfermedad inflamatoria intestinal en una clínica de cuarto nivel en Cali
2020 · Carlos Arturo Rojas Rodríguez, Santiago Sánchez Londoño, et al. · Revista Colombiana de Gastroenterología · 4
PDF
EE403 Economic Analysis of Dupilumab Use in Patients With Chronic Rhinosinusitis With Nasal Polyps in Colombia
2023 · A. Upegui, P. Cadena, et al. · Value in Health · 1
PND19 Budget IMPACT Modelling for Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients in Colombia
2020 · S. Londono, N. Gomez · Value in Health · 1
Perforación esofágica en niños tratada con stents biliares recubiertos: serie de tres casos en un hospital de alta complejidad en Medellín, Colombia
2026 · Daniela Londoño-Cañas, Álvaro Gómez Vanegas, et al. · Revista de Gastroenterología del Perú
PDF
CO154 Impact of Dupilumab on Healthcare Resource Utilization in Severe Asthma: Real-World Evidence in Colombia
2024 · A Ali, J Zakzuk, et al. · Value in Health
CO115 LDL-C Goals Attainment in Patients at Very High Cardiovascular Risk: A Multicentric RWE Evaluation in Colombia
2024 · B Cordoba, H Leon Giraldo, et al. · Value in Health
PDF
HTA135 Isatuximab for the Third-Line Treatment of Relapsing or Refractory Multiple Myeloma: Therapeutic Value Classification in Colombia
2024 · C Castro, B Patiño Escobar, et al. · Value in Health
PDF
EE120 Economic Burden of Pompe Disease in Colombia
2024 · Pachon A Upegui, C Chacon, et al. · Value in Health
PDF
EE316 Economic Burden of Fabry Disease in Colombia
2024 · Pachon A Upegui, J Becerra, et al. · Value in Health
PDF
EE9 Economic Burden of Gaucher Disease in Colombia
2024 · Pachon A Upegui, L Mora, et al. · Value in Health
PDF
EE18 Economic Burden of Type 2 Diabetes in Peru: A Cost-of-Illness Study Valuing Cost Differences Associated With the Level of Glycemic Control
2023 · J. Seinfeld, A. Sobrevilla, et al. · Value in Health
PDF
EE621 Cost-Effectiveness Analysis of iGlarLixi Compared With Basal Bolus Insulin Regimen in Triple Metabolic Goal in Type 2 Diabetes Mellitus in Latin America
2023 · S. Londono, W. Garcia, et al. · Value in Health
EE322 A Cost Analysis for Macrovascular Events, Comparison of Glargine 300U/Ml (GLA-300) and Degludec 100U/Ml (IDeg-100) in the Treatment of Type 2 Diabetes Mellitus in Older Population or Renal Impairment Individuals in Latin America
2023 · S. Londono, W. Garcia, et al. · Value in Health
PDF
EE345 Clinical and Economic Impact Analysis of Viscosupplementation With Hylan G-F 20 Versus Hyaluronic Acid for the Treatment of Knee Osteoarthrosis in Colombia
2023 · E. Vásquez, P. Lasalvia, et al. · Value in Health
HSD57 Adherence Teleassistance-Based Program Impact in a Real-Life Diabetes Colombian Patient Cohort
2023 · S. Mejia-Torres, C. Camacho-Misol, et al. · Value in Health
PDF
HTA87 Caplacizumab for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (ATTP): Technology Qualification in Colombia
2023 · J. Soto, L.M. Gomez, et al. · Value in Health
CO188 Clinical Characteristics of Statin Management in a Cohort with Cardiovascular Risk in Colombia
2023 · V. Aldana, C.C. Vera, et al. · Value in Health
PDF
EE176 A Cost Analysis on Complications of Fabry Disease Patients Treated with Agalsidase Alfa and Agalsidase Beta in Colombia
2023 · S. Londono, M.E. Ossa, et al. · Value in Health
PDF
EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia
2023 · S. Londono, Y. Gil-Rojas, et al. · Value in Health
PDF
EE293 A Cost Analysis on Renal Disease Progression of Fabry Disease Patients Treated with Agalsidase Beta Based on Renal Disease Stage in Colombia
2023 · S. Londono, M.E. Ossa, et al. · Value in Health
PDF
HPR112 Systematic Review for Rare Diseases Policy: A Sight in Peru and Colombia
2023 · S. Perez, A. Upegui, et al. · Value in Health
PDF
EE330 A Cost Analysis for Major Cardiovascular Events in Influenza Vaccinated and Unvaccinated Patients after Myocardial Infarction in Colombia
2023 · L. Zambrano, D.A. Solano, et al. · Value in Health
PDF
EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19
2022 · J Seinfeld, A Sobrevilla, et al. · Value in Health
PDF
EE247 Public Health Impact of Switching From a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in the Dominican Republic
2022 · I Zerda, M Gorecki, et al. · Value in Health
PCR115 Measurement of Therapeutic Adherence in Orphan Diseases: A Scoping Review
2022 · L Zambrano, ME Ossa, et al. · Value in Health
Works count: 33
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type